PLGA, PLG, or poly (lactic-co-glycolic) acid (CAS: 26780-50-7 ) is a copolymer which is used in a host of Food and Drug Administration (FDA) approved therapeutic devices, owing to its biodegradability and …

In past two decades poly lactic-co-glycolic acid (PLGA) has been among the most attractive polymeric candidates used to fabricate devices for drug delivery and tissue engineering applications.

Jul 20, 2025 · PLGA is a biocompatible polymer engineered to safely break down in the body. Its tunable degradation rate makes it a versatile platform for medical innovation.

PLGA Poly (lactic-co-glycolic acid) (PLGA) is made from two monomers, lactic acid and glycolic acid. The ratio of the monomers and the molecular weight set the identity and properties. For example, …

Sep 1, 2022 · PLGA-based formulations have enabled drug targeting and improved bioavailability.

SUMMARY PLGA is widely used as an alternative drug delivery system for injectable drugs as a long-acting excipient. It forms microspheres that allows slow or control release of drugs. It is …

Nov 22, 2025 · Lactic Acid/Glycolic Acid Copolymer (PLGA) is a polymer consisting of Lactic and Glycolic acid units (monomers) specially designed to improve ingredient delivery systems, especially …

Apr 27, 2025 · Poly (lactide-co-glycolide) (PLGA) implants have become a cornerstone in drug delivery and regenerative medicine due to their biocompatibility, tunable degradation, and capacity for …

1. Introduction PLGA is a pivotal material in biomedical engineering, extensively utilized for its biocompatibility, tunable degradation, and adaptability in drug delivery and tissue engi-neering.

1. Introduction PLGA is a pivotal material in biomedical engineering, extensively utilized for its biocompatibility, tunable degradation, and adaptability in drug delivery and tissue engineering.